A $244,000 profit is not much to hold up against a $4.9 million operating cash outflow. For Trilogy Metals, the three months ended August 31 produced the former on paper and the latter in cash, a small three-month period with a rather large accounting footnote.
The headline change looks dramatic: net income moved from a $1.7 million loss in the comparable three months to a $244,000 profit. At the latest close, Trilogy shares were $3.06, down 1.0% for the day. The more useful question is what created the profit.
Management says the answer was a mark on a derivative liability tied to the company's obligation to issue shares and warrants to the United States Department of War. The adjustment is non-cash, meaning it changes reported earnings without putting money into the bank.
"The net income was primarily driven by a mark-to-market gain arising from the change in fair value of the derivative liability related to our obligation to issue shares and warrants to the U.S."
Trilogy Metals, 10-Q, October 2, 2026
That gain turned a small operating result into a small net profit. It did not reverse the company's cash use. Operating cash flow worsened from negative $2.7 million to negative $4.9 million versus the comparable period, even as cash on the balance sheet rose from $23.4 million to $31.2 million. The filing does not identify the source of that cash increase in the supplied comparison.
The other side of the ledger is Ambler Metals, where Trilogy said exploration spending increased its share of the equity investment loss. Personnel costs also rose with the addition of senior staff. Those are operating developments, unlike the derivative remeasurement, and they point in the opposite direction from the reported net-income swing.
"The increase in our share of loss from Ambler Metals was primarily driven by budgeted exploration activities undertaken during the period."
Trilogy Metals, 10-Q, October 2, 2026
The balance sheet also carries a quieter signal. Diluted shares increased 5.2% to 172.8 million from 164.3 million a year earlier. Trilogy warns that future warrant exercise could dilute shareholders further, subject to the specified conditions. The filing therefore presents two different ways to read the same period: earnings improved because of a non-cash fair-value gain, while cash consumption and the share count moved higher.
The $11.6 million mark-to-market adjustment gives scale to the accounting effect. It was many times larger than the reported profit, which is why the bottom line can look repaired even when the operating cash line is not. A receivables balance that rose from $17,000 to $93,000 is also notable in percentage terms, though still small in dollars.
Trilogy's next report will put a fresh number on the derivative liability and show whether the reported earnings line is again being shaped by that non-cash mark, alongside operating cash flow and Ambler spending. For now, the period's trade-off is simple: profitable on paper, cash-negative in practice.